Identification of Rinvoq:

No description

Search images on Google      Product Monograph

Active Ingredients:

• upadacitinib, 45 MG

DIN: 02539721

Dosage Form(s): TABLET (EXTENDED-RELEASE)

Route(s) of Administration: ORAL

Schedule: Prescription

Company: ABBVIE CORPORATION

ATC:

• L04 - IMMUNOSUPPRESSANTS (ATC, WHO, Wiki)
• L04A - IMMUNOSUPPRESSANTS (ATC, WHO)
• L04AF - (ATC, WHO)
• L04AF03 - UPADACITINIB (WHO)

 

External Links for Rinvoq:

Search on Google

• Rinvoq side effects
• Rinvoq dosage
• upadacitinib side effects
• upadacitinib dosage